Amplyx APX001-103 (#735)
Laufzeit: 01.01.2018 - 31.12.2019
imported
Kurzfassung
An open label, multicenter study to determine the safety and pharmacokinetics of intravenous and oral APX001 in patients undergoing chemotherapy for ácute myeloid leukemia with neutropenia
